BAART PROGRAMS OMAHA WEST
NPI 1073874731
Clinic/Center - Methadone in Omaha, NE

Active since May 30, 2012CLIA 28D2255694 · Waiver
11215 JOHN GALT BLVD., OMAHA, NE 68137(402) 592-5900(402) 592-5901 Get Directions Write a Review

NPPES record last updated: July 29, 2024. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Jul 29, 2024, Feb 28, 2023, Feb 12, 2021 (3 updates tracked since 2021).

About Baart Programs Omaha West NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

BAART PROGRAMS OMAHA WEST (NPI 1073874731) is a healthcare organization registered as a methadone in Omaha, Nebraska and active in the NPI registry since May 2012. The organization holds a CLIA Waiver certificate valid through March 15, 2028 and lists Bruce Jarvie, Vp, Treasurer, as its authorized official.

NPPES Registry Identity

NPI1073874731
Entity TypeOrganization
Primary Taxonomy261QM2800X
Legal Business NameOMAHA TREATMENT CENTER, LLC
Location Address11215 JOHN GALT BLVD.Omaha, NE 68137
Mailing Address1720 Lakepointe Dr Ste 117Lewisville, TX 75057-6425 · (214) 379-3300
Fax(402) 592-5901
Organization SubpartNo
Authorized OfficialBruce JarvieVp, Treasurer · (214) 379-3300
Enumeration DateMay 30, 2012
Last NPPES UpdateJuly 29, 20243 updates tracked since enumeration
NPPES CertifiedJuly 29, 2024
NPI 1073874731 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 3

Primary SpecialtyClinic/Center · MethadoneAmbulatory Health Care Facilities
Taxonomy Code261QM2800X
Definition
An entity, facility, or distinct part of a facility providing diagnostic, and replacement maintenance treatment services related to individuals with drug addiction.
Also ListedCommunity/Behavioral HealthTaxonomy 251S00000X · License SATA144 (NE)
11215 JOHN GALT BLVD., Omaha, NE 68137

Other Names 1

Doing Business AsBaart Programs Omaha West

Accepted Insurance

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 28D2255694

Omaha Treatment Center, LLC Baart Programs Omaha West · Omaha, NE
Active · expires Mar 15, 2028
CLIA Number28D2255694
Laboratory TypeNarcotic Treatment Prgm
Certificate Effective DateMarch 16, 2026
Certificate Expiration DateMarch 15, 2028
Laboratory DirectorDr. Gerald Langdon
Laboratory Phone(402) 592-5900
Laboratory LocationOmaha Treatment Center, LLC Baart Programs Omaha West11215 John Galt Boulevard, Omaha, NE 68137
CLIA data matches this NPI record on: Address Name Phone
This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 4

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm G2067
Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.
327 services18 patients
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure G2078
This service provides an additional 7-day supply of methadone, a medication used to treat opioid addiction, for patients to take at home. It's provided by a Medicare-enrolled opioid treatment program. This service is billed separately from the main treatment procedure.
316 services16 patients
Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for G2077
Periodic assessment is a routine check-up by trained professionals to determine the best mix of services and treatments for your health needs. This is typically provided by a Medicare-enrolled opioid treatment program. It's listed separately in addition to your main treatment code. This ensures you receive the most suitable care for your situation.
70 services12 patients
Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) G2074
Medication Assisted Treatment is a comprehensive program for managing substance use. It includes counseling (both individual and group), along with regular toxicology testing if required. This service is provided by a Medicare-enrolled opioid treatment program.
69 services13 patients

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Omaha Treatment Center, LLC's NPI number?

The NPI number for Omaha Treatment Center, LLC is 1073874731. It was assigned to this organization in the NPPES registry on May 30, 2012. The provider is doing business as Baart Programs Omaha West.

Where is Omaha Treatment Center, LLC located?

Omaha Treatment Center, LLC is located at 11215 John Galt Blvd., Omaha, NE 68137. The listed phone number is (402) 592-5900.

What is Omaha Treatment Center, LLC's specialty?

The primary specialty registered for this NPI is Clinic/Center, specializing in Methadone, with taxonomy code 261QM2800X.

Does Omaha Treatment Center, LLC hold a CLIA laboratory certificate?

Yes. A Certificate of Waiver (number 28D2255694) is associated with this NPI, valid through March 15, 2028. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.

What insurance does Omaha Treatment Center, LLC accept?

Health plans from Ambetter Health, Ambetter Health of Delaware, Ambetter from Home State Health and Ambetter from Sunflower Health Plan list Omaha Treatment Center, LLC as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Omaha Treatment Center, LLC was last updated on July 29, 2024. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 2 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.